Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Solid Tumors in Children”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01164163
What this trial is testing

INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+2 more
Children's Oncology Group 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT02574728
What this trial is testing

Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors

Who this might be right for
Cancer
Emory University 46
Early research (Phase 1)Not Yet RecruitingNCT07773454
What this trial is testing

Study of Zanzalintinib in Children and Adolescents With Relapsed or Refractory Solid Tumors

Who this might be right for
CancerPediatric Cancer
Exelixis 18
Testing effectiveness (Phase 2)Looking for participantsNCT03465592
What this trial is testing

Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma

Who this might be right for
SarcomaSolid Tumor, AdultSolid Tumor, Childhood
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 39
Early research (Phase 1)Study completedNCT01670175
What this trial is testing

Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid Tumors

Who this might be right for
Malignant Solid TumorChildhood Solid Tumor
University of California, San Francisco 21
Early research (Phase 1)Study completedNCT01725191
What this trial is testing

Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
Childhood Solid Neoplasm
National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT01273090
What this trial is testing

Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaLymphoproliferative Disorder+2 more
Children's Oncology Group 34
Early research (Phase 1)Study completedNCT01282697
What this trial is testing

Clinical Trial of Rapamycin and Irinotecan in Pediatric Patients With Refractory Solid Tumors

Who this might be right for
Refractory Solid Tumors in Children
University Hospital, Strasbourg, France 42
Early research (Phase 1)Study completedNCT00024284
What this trial is testing

Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors

Who this might be right for
Unspecified Childhood Solid Tumor, Protocol Specific
Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT00049023
What this trial is testing

Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more
O'Dorisio, M S 27
Testing effectiveness (Phase 2)Study completedNCT02372006
What this trial is testing

Trial of Afatinib in Pediatric Tumours

Who this might be right for
Neuroectodermal TumorsRhabdomyosarcoma
Boehringer Ingelheim 56
Early research (Phase 1)Ended earlyNCT02687386
What this trial is testing

Intravenous EEDVsMit in Children With Recurrent / Refractory Solid or CNS Tumours Expressing EGFR

Who this might be right for
Solid TumoursCNS Tumours
Dr David Ziegler 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07444918
What this trial is testing

Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors

Who this might be right for
Relapsed or Refractory Pediatric Malignant Solid Tumors (Including Neuroblastoma, Rhabdomyosarcoma, Ewing Sarcoma, Osteosarcoma)
Tianjin Medical University Cancer Institute and Hospital 33
Testing effectiveness (Phase 2)Ended earlyNCT03458728
What this trial is testing

Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients

Who this might be right for
Relapsed or Refractory Solid Tumors or Lymphoma in ChildrenNeuroblastomaOsteosarcoma+2 more
Bayer 31
Not applicableStudy completedNCT01053494
What this trial is testing

Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAngioimmunoblastic T-cell Lymphoma+84 more
Wake Forest University Health Sciences 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT02867592
What this trial is testing

Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

Who this might be right for
Adrenal Cortical CarcinomaAlveolar Soft Part SarcomaCentral Nervous System Neoplasm+41 more
National Cancer Institute (NCI) 109
Early research (Phase 1)Study completedNCT02171260
What this trial is testing

This is a Phase 1 Study of Eribulin Mesylate in Pediatric Participants With Recurrent or Refractory Solid Tumors (Excluding [Central Nervous System] CNS), Including Lymphomas

Who this might be right for
PediatricsSolid Tumors
Eisai Inc. 23
Early research (Phase 1)Study completedNCT01259479
What this trial is testing

Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors

Who this might be right for
Solid TumorsBrain TumorsBrain Metastases
National Cancer Institute (NCI) 9
Early research (Phase 1)Study completedNCT00016861
What this trial is testing

Irinotecan in Treating Children With Refractory or Progressive Solid Tumors

Who this might be right for
Unspecified Childhood Solid Tumor, Protocol Specific
Texas Children's Cancer Center
Early research (Phase 1)Looking for participantsNCT07358260
What this trial is testing

B7-H3.CD28Z.CART in Solid Tumors

Who this might be right for
Pediatric Solid TumorNeuroblastoma
Robbie Majzner 40
Next Page